Abstract

Conventional drugs have long been the cornerstone of treatment for various complex diseases, including cancer, autoimmune disorders, and rare genetic conditions. This article reviews the mechanisms of action, efficacy, and limitations of conventional pharmacological therapies in managing these diseases. By examining recent advancements and ongoing research, we highlight the critical role of conventional drugs while also acknowledging the necessity for personalized treatment strategies. The findings suggest that although conventional drugs have significant therapeutic potential, their effectiveness is often limited by factors such as disease heterogeneity and drug resistance. Future research should focus on integrating conventional therapies with innovative approaches to enhance patient outcomes.